Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

Biogen joins COVID-19 efforts with $10m support fund

Funds will be used to address 'immediate critical needs'

- PMLiVE

First patients dosed with Moderna’s COVID-19 vaccine

More pharma players also join vaccine development efforts

- PMLiVE

Novo Nordisk hits pause on rival to Hemlibra for haemophilia

Halts three studies because of safety concerns

- PMLiVE

UK ramps up measures to combat coronavirus spread

New advice encourages ‘social-distancing’ as cases expected to soar

- PMLiVE

Why pharma should invest in the education of doctors

By Tim Russell, Heather Hancock and Deepak Jadon

- PMLiVE

For those who love science and storytelling — consider medical writing

In NetworkPharma’s latest career guide for wannabe medical writers, Kat Schleicher discusses how her love of science and storytelling makes medical writing the perfect career choice for her:​I love science!...

Lucid Group Communications Limited

- PMLiVE

Sanofi, Regeneron launch trials of arthritis drug Kevzara for COVID-19

The interleukin-6 inhibitor will be evaluated in critically ill patients

- PMLiVE

CEPI says $2bn is needed for COVID-19 vaccine development

Funding will be used to take candidates through all stages of development

- PMLiVE

Merck KGaA, Pfizer’s Bavencio stumbles in head and neck cancer

Checkpoint inhibitor unlikely to improve progression-free survival

- PMLiVE

NHS England will make PrEP for HIV available in April

Will be made available to patients at risk of contracting infection

- PMLiVE

Did Trump offer CureVac $1bn for COVID-19 vaccine rights?

Media reports claim Trump administration tried to secure exclusive rights

Great expectations: the urgent need for common purpose in Alzheimer’s disease

By Andrew Harrison

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links